# Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19

> **NCT04392531** · PHASE4 · COMPLETED · sponsor: **Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz** · enrollment: 111 (actual)

## Conditions studied

- COVID19 Infection

## Interventions

- **DRUG:** Cyclosporine
- **DRUG:** Standard treatment

## Key facts

- **NCT ID:** NCT04392531
- **Lead sponsor:** Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-16
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04392531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04392531, "Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04392531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*